EBF 4th Open Symposium - Update EMA BMV session

		Day 1 – 16 November 2011
		MORNING PLENARY SESSIONS
11.20	12.45	How To Implement The EMA Guideline On Bioanalytical Method Validation
		Chair and Moderator: Silke Luedtke (Boehringer-Ingelheim)
11.20	11.25	Peter van Amsterdam (on behalf of EBF)
		Introduction
11.25	11.35	Olivier Le Blaye (afssaps)
		< Title to be confirmed >
11.35	11.45	Timothy Sangster (Charles River Laboratories)
		EMA – have our prayers been answered!
11.45	11.55	Daniela Stoellner (Novartis)
		New EMA guideline on method validation and how it translates into best practice for Ligand Binding Assays
11.55	12.05	Graeme Smith (Huntingdon Life Sciences)
		Partial Validation when is enough, enough?
12.05	12.15	Morten Rohde (Lundbeck)
		Matrix Effects in Bioanalysis, when established procedures become obsolete.
12.15	12.45	Panel Discussion

To download the full program, follow this link.